A5038668816- Coronary Interventions and Diagnostics
- Cardiac Imaging and Diagnostics
- Cardiac Valve Diseases and Treatments
- Acute Myocardial Infarction Research
- Atrial Fibrillation Management and Outcomes
- Infective Endocarditis Diagnosis and Management
- Venous Thromboembolism Diagnosis and Management
- Antiplatelet Therapy and Cardiovascular Diseases
- Cardiovascular Function and Risk Factors
- Cardiac Arrhythmias and Treatments
- Vascular Procedures and Complications
- Cardiac pacing and defibrillation studies
- Acute Ischemic Stroke Management
- Cardiac, Anesthesia and Surgical Outcomes
- Cerebrovascular and Carotid Artery Diseases
- Aortic Disease and Treatment Approaches
- Peripheral Artery Disease Management
- Takotsubo Cardiomyopathy and Associated Phenomena
- Heart Failure Treatment and Management
- Parathyroid Disorders and Treatments
- Coronary Artery Anomalies
- Pulmonary Hypertension Research and Treatments
- Health Systems, Economic Evaluations, Quality of Life
- Cardiac and Coronary Surgery Techniques
- Case Reports on Hematomas
Sovah Health Martinsville
2024-2025
MedStar Washington Hospital Center
2022-2024
Washington Hospital
2022-2023
MedStar Georgetown University Hospital
2022-2023
Georgetown University
2022-2023
MedStar Health
2023
MedStar Heart & Vascular Institute
2023
Vanderbilt University Medical Center
2023
Ted Rogers Centre for Heart Research
2023
University Health Network
2023
Background: The LRT trial (Low-Risk Transcatheter Aortic Valve Replacement [TAVR]) demonstrated the safety and feasibility of TAVR in low-risk patients, with excellent 1- 2-year outcomes. objective current study is to provide overall clinical outcomes impact 30-day hypoattenuated leaflet thickening (HALT) on structural valve deterioration at 4 years. Methods: prospective, multicenter was first Food Drug Administration-approved investigational device exemption evaluate patients symptomatic...
Abstract Background The Evolut self‐expanding valve (SEV) systems (Medtronic), were designed to accommodate varying sizes and reduce paravalvular leak (PVL) while maintaining a low delivery profile. These have evolved between product generations, alongside deployment techniques changing over time. Aims: This study aimed examine whether these changes impacted clinical outcomes. Methods EPROMPT is prospective, investigator‐initiated, postmarketing registry of consecutive patients undergoing...